Post-Conference Perspectives: Advances in the Management of Newly Diagnosed Ph+ Acute Lymphoblastic Leukemia : Episode 4
Ponatinib and Blinatumomab Use in Patients with Newly Diagnosed Ph+ ALL
Dr Aldoss discusses the role ponatinib and blinatumomab in the management of Ph+ALL.
EP: 1.Defining and Diagnosing Philadelphia Chromosome-Positive (Ph+) ALL
EP: 2.Evolving Standard of Care for Patients Diagnosed with Ph+ ALL
EP: 3.Recent Updates from the PhALLCON Study
Now Viewing
EP: 4.Ponatinib and Blinatumomab Use in Patients with Newly Diagnosed Ph+ ALL
EP: 5.Notable Advancements in Treatment for ALL
EP: 6.Unmet Needs and Treatment Trajectory for Patients Diagnosed with Ph+ ALL
Related Videos
Related Content
